Clover Health Investments Corp.
CLOV | NASDAQ
$4.58
+$0.04 (+0.88%)
Sep 22, 2026, 2:24 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 743.17M | 749.19M | 487.71M | 496.65M | 477.62M | 462.33M | 336.96M | 330.99M | 356.26M | 346.92M | 510.25M | 306.03M | 320.14M | 321.99M | 898.79M | 856.82M | 846.7M | 874.38M | 432.04M | 427.16M | 412.47M | 200.33M |
Cost of Revenue | 590.17M | 589.65M | 413.5M | 423.47M | 377.99M | 353.44M | 243.04M | 249.77M | 248.35M | 265.16M | 447.99M | 235.79M | 244.26M | 274.79M | 893.65M | 839.8M | 858.79M | 861.72M | 441.8M | 436.33M | 458.5M | 214.42M |
Gross Profit | 153M | 159.54M | 74.21M | 73.18M | 99.63M | 108.89M | 93.92M | 81.21M | 107.91M | 81.76M | 62.27M | 70.24M | 75.88M | 47.2M | 5.15M | 17.02M | -12.09M | 12.66M | -9.77M | -9.16M | -46.03M | -14.1M |
Operating Income | 28M | 27.33M | -49.32M | -24.38M | -10.56M | -1.27M | -21.45M | -8.79M | 7.19M | -22.7M | -65.66M | -33.62M | -28.88M | -79.7M | -107.16M | -74.1M | -102.73M | -87.48M | -186.79M | -149.25M | -181.86M | -119.09M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 28M | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -21.48M | -8.79M | 7.17M | -23.17M | -70.47M | -33.62M | -28.89M | -79.7M | -84.05M | -75.49M | -104.36M | -75.49M | -187.2M | -34.53M | -317.61M | -48.42M |
Net Income | 28M | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -22.09M | -9.16M | 7.41M | -19.17M | -70.47M | -41.47M | -28.81M | -72.61M | -84.05M | -75.49M | -104.36M | -75.49M | -187.2M | -34.53M | -317.61M | -48.42M |
Selling & General & Admin | 124.44M | 131.69M | -140.31M | 97.15M | 109.79M | 109.7M | 115.02M | 90.2M | 99.92M | 103.79M | 109.93M | 101.6M | 104.15M | 126.63M | 124.35M | 117.97M | 117.53M | 126.79M | 114.21M | 119.21M | 107.81M | 104.64M |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 564K | 515K | 263.84M | 406K | 394K | 466K | 344K | -199K | 803K | 671K | 18M | 2.26M | 611K | 276K | -12.04M | -26.86M | -26.89M | -26.65M | 62.82M | 20.88M | 28.02M | 351K |
Operating Expenses | 125M | 132.21M | 123.53M | 97.55M | 110.19M | 110.16M | 115.37M | 90M | 100.73M | 104.46M | 127.93M | 103.86M | 104.76M | 126.9M | 112.31M | 91.11M | 90.64M | 100.14M | 177.02M | 140.09M | 135.83M | 104.99M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 7K | n/a | 139K | 413K | 408K | 403K | 412K | 426K | 1.24M | 14.84M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 715.17M | 721.86M | 537.03M | 521.03M | 488.18M | 463.61M | 358.41M | 339.77M | 349.07M | 369.63M | 575.91M | 339.64M | 349.02M | 401.69M | 1.01B | 930.91M | 949.43M | 961.86M | 618.83M | 576.42M | 594.33M | 319.41M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 524.19M | 522.18M | 517.24M | 512.74M | 508.89M | 497.06M | 491.87M | 490.18M | 487.48M | 486.37M | 481.61M | 480.77M | 479.16M | 478.81M | 477.9M | 477.69M | 476.06M | 473.03M | 470.85M | 420.63M | 408.31M | 376.17M |
Shares Outstanding (Diluted) | 545.45M | 532.5M | 517.24M | 512.74M | 508.89M | 497.06M | 491.87M | 490.18M | 495.18M | 567.45M | 481.61M | 480.77M | 479.16M | 478.81M | 477.9M | 477.69M | 476.06M | 473.03M | 470.85M | 420.63M | 408.31M | 376.17M |
EPS (Basic) | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 | 0 | -0.04 | -0.02 | 0.01 | -0.04 | -0.15 | -0.09 | -0.06 | -0.15 | -0.18 | -0.16 | -0.22 | -0.16 | -0.40 | -0.08 | -0.78 | -0.13 |
EPS (Diluted) | 0.05 | 0.05 | -0.10 | -0.05 | -0.02 | 0 | -0.04 | -0.02 | 0.01 | -0.04 | -0.15 | -0.09 | -0.06 | -0.15 | -0.18 | -0.16 | -0.22 | -0.16 | -0.40 | -0.08 | -0.78 | -0.13 |
EBITDA | 28.57M | 27.85M | -48.9M | -23.97M | -10.18M | -808K | -21.14M | -8.98M | 7.5M | -22.03M | -69.8M | -33.06M | -27.88M | -77.61M | -84.75M | -74.46M | -103.37M | -74.26M | -185.94M | -33.98M | -316.26M | -33.42M |
EBIT | 28M | 27.33M | -49.32M | -24.38M | -10.58M | -1.27M | -21.48M | -9.32M | 7.17M | -22.35M | -70.47M | -33.62M | -28.88M | -77.89M | -83.91M | -75.08M | -103.95M | -75.09M | -186.79M | -34.1M | -316.37M | -33.58M |
Depreciation & Amortization | 564K | 515K | 420K | 406K | 394K | 466K | 344K | 339K | 330K | 318K | 674K | 557K | 999K | 279K | -841K | 616K | 586K | 826K | 848K | 120K | 118K | 160K |
Add to Watchlist
Select watchlists to add or remove CLOV